about
VAP-1/SSAO plasma activity and brain expression in human hemorrhagic strokeGRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence After Stroke.A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.Brain perihematoma genomic profile following spontaneous human intracerebral hemorrhageDoor-to-puncture: a practical metric for capturing and enhancing system processes associated with endovascular stroke care, preliminary results from the rapid reperfusion registry.Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.Emergent Carotid Stenting After Thrombectomy in Patients With Tandem Lesions.Monitoring clot dissolution during intravenous thrombolysis.Training Guidelines for Endovascular Stroke Intervention: An International Multi-Society Consensus Document.A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.Improving the Evaluation of Collateral Circulation by Multiphase Computed Tomography Angiography in Acute Stroke Patients Treated with Endovascular Reperfusion Therapies.CBV_ASPECTS Improvement over CT_ASPECTS on Determining Irreversible Ischemic Lesion Decreases over TimeStrokes and their relationship with sleep and sleep disorders.Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type.Transcervical access in acute ischemic stroke.Combination of Thrombolysis and Statins in Acute Stroke Is Safe: Results of the STARS Randomized Trial (Stroke Treatment With Acute Reperfusion and Simvastatin).Association Between Time to Reperfusion and Outcome Is Primarily Driven by the Time From Imaging to Reperfusion.Mechanical Thrombectomy in and Outside the REVASCAT Trial: Insights From a Concurrent Population-Based Stroke Registry.Ischemic stroke outcome: A review of the influence of post-stroke complications within the different scenarios of stroke care.NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia.Perfusion augmentation in acute stroke using mechanical counter-pulsation-phase IIa: effect of external counterpulsation on middle cerebral artery mean flow velocity in five healthy subjects.Real-time validation of transcranial Doppler criteria in assessing recanalization during intra-arterial procedures for acute ischemic stroke: an international, multicenter study.Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator.Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.Thrombectomy within 8 hours after symptom onset in ischemic stroke.Training guidelines for endovascular stroke intervention: an international multi-society consensus document.Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.The I/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals.Oxidative stress after thrombolysis-induced reperfusion in human stroke.Cognitive improvement in patients with severe carotid artery stenosis after transcervical stenting with protective flow reversal.Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.Thrombolysis in anterior versus posterior circulation strokes: timing of recanalization, ischemic tolerance, and other differences.Therapeutic interventions and success in risk factor control for secondary prevention of stroke.Geographic differences in acute stroke care in Catalunya: impact of a regional interhospital network.[Hospital care of stroke patients: importance of expert neurological care].Pattern of response of National Institutes of Health Stroke Scale components to early recanalization in the CLOTBUST trial.IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke.Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence.
P50
Q28254480-BC6225E6-6B7F-414A-BE12-9AE0F6DA185EQ30252625-E429D037-8A13-46A7-92A3-93674AFD1741Q30425406-B57D462C-8721-4CCA-8D01-32AACA16EA23Q31048053-CEB3BC19-AE28-4FC3-A042-68181A1AA2B8Q33818147-1C43E227-1B05-4CFD-A501-6F780784CC45Q34297194-B0CD2336-B874-4DAC-9F89-109FA0207FEFQ34648243-957779FD-2548-4D59-95D5-7CDC025530E9Q36307920-D8983B0E-6702-4272-AB97-7EB508DB10BBQ36541428-4A1AF12D-C069-47AE-B920-E3A0CBC5221AQ37069150-7D50C382-A46E-4C91-B7F1-3278CF60CF20Q37109747-0B91905E-D8BC-472E-97E1-FA4393406625Q37325248-800111B3-EEA5-415D-88CC-82459EA88DEEQ37360199-61A60383-9EBE-4839-A039-D43D084BDFA8Q37821525-6C2FFF61-615D-45C7-93C2-4C8B3D3E92F7Q37936617-1840E9A1-6658-486F-859A-85BC71A66E42Q38160818-92507B3B-C25F-4305-B967-C0514B5B0C74Q38385898-2935622E-385A-4965-94EB-ED6FF32E6676Q38395031-3C6E9FEC-64E5-4C45-B881-847C0809E844Q38401318-5163A0E6-81EE-4AA5-9AFE-C781CDB47E83Q38684920-B2A50983-DCFC-4D47-9610-5E393452283BQ38928837-C63B5E05-1FE1-4BDD-9999-8E83BE0CE6EEQ39874415-2447B6B6-6AC1-4038-B79B-44C04CA44468Q40066008-9F389703-2864-4AE0-8412-6D47679E7B44Q40085016-DE378F24-FD8A-4F21-B2FF-9699DE417BE5Q40497898-17CA7C48-C77E-4FA1-8456-21E46EC98BB6Q40607050-47ACCE73-CBBD-4CE0-A86F-3C73BF580EC0Q41060802-801A4D96-735C-4BF5-B8DB-BBCD9AAE81D3Q42767630-88F2CD44-1023-452D-83F2-16BD892D0978Q43031253-7996F1AE-A627-44DC-BA48-DD462A1A99FEQ43093844-7AB07A6E-1573-42FA-85A5-DFA9A9EDFB0BQ43149020-1A96FAA5-63D4-402F-AEBD-61926D1DCB6AQ43417419-C852F838-29D4-482D-9BC8-8AB8A1C2667CQ43529232-E730509F-9D87-49D9-B217-07E68669CFB0Q43672781-1C0036CD-4BAF-4ABE-94A0-CB9D0751147BQ43792326-730BE70D-FF05-4472-845C-F66A24BFE581Q43803409-E85F4284-C393-41E6-9086-32FDA8721F88Q43969127-E0A7AB09-713E-4950-BAD2-09B2EFDBCE78Q44049818-1F2154A2-E3B3-4006-80D7-BCCC1CAAB553Q44074071-2A8B1EA1-9A8A-49C8-9B19-2DB73F5D076AQ44322045-D8A5774E-48C5-4DBE-90C4-411954197E35
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marc Ribo
@ast
Marc Ribo
@en
Marc Ribo
@es
Marc Ribo
@nl
Marc Ribo
@sl
type
label
Marc Ribo
@ast
Marc Ribo
@en
Marc Ribo
@es
Marc Ribo
@nl
Marc Ribo
@sl
prefLabel
Marc Ribo
@ast
Marc Ribo
@en
Marc Ribo
@es
Marc Ribo
@nl
Marc Ribo
@sl
P106
P21
P31
P496
0000-0001-9242-043X